Follow
Cristina Ivan
Cristina Ivan
Caris Life Sciences
Verified email at carisls.com
Title
Cited by
Cited by
Year
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis
SA Melo, H Sugimoto, JT O’Connell, N Kato, A Villanueva, A Vidal, L Qiu, ...
Cancer cell 26 (5), 707-721, 2014
16042014
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
H Ling, R Spizzo, Y Atlasi, M Nicoloso, M Shimizu, RS Redis, N Nishida, ...
Genome research 23 (9), 1446-1461, 2013
6752013
PDL1 Regulation by p53 via miR-34
MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ...
Journal of the National Cancer Institute 108 (1), djv303, 2016
5912016
PD-L1 expression and prognostic impact in glioblastoma
EK Nduom, J Wei, NK Yaghi, N Huang, LY Kong, K Gabrusiewicz, X Ling, ...
Neuro-oncology 18 (2), 195-205, 2015
5502015
Dementia after stroke: the Framingham Study
CS Ivan, S Seshadri, A Beiser, R Au, CS Kase, M Kelly-Hayes, PA Wolf
Stroke 35 (6), 1264-1268, 2004
5442004
Tumour angiogenesis regulation by the miR-200 family
CV Pecot, R Rupaimoole, D Yang, R Akbani, C Ivan, C Lu, S Wu, HD Han, ...
Nature communications 4 (1), 2427, 2013
4302013
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy
KB Challagundla, PM Wise, P Neviani, H Chava, M Murtadha, T Xu, ...
Journal of the National Cancer Institute 107 (7), djv135, 2015
3682015
Loss of p53 drives neuron reprogramming in head and neck cancer
M Amit, H Takahashi, MP Dragomir, A Lindemann, FO Gleber-Netto, ...
Nature 578 (7795), 449-454, 2020
2722020
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
S Melo, A Villanueva, C Moutinho, V Davalos, R Spizzo, C Ivan, S Rossi, ...
Proceedings of the National Academy of Sciences 108 (11), 4394-4399, 2011
2662011
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
A Ferrajoli, TD Shanafelt, C Ivan, M Shimizu, KG Rabe, N Nouraee, ...
Blood, The Journal of the American Society of Hematology 122 (11), 1891-1899, 2013
2442013
TP53 loss creates therapeutic vulnerability in colorectal cancer
Y Liu, X Zhang, C Han, G Wan, X Huang, C Ivan, D Jiang, ...
Nature 520 (7549), 697-701, 2015
2392015
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 5203, 2014
2302014
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells
MI Almeida, MS Nicoloso, L Zeng, C Ivan, R Spizzo, R Gafà, L Xiao, ...
Gastroenterology 142 (4), 886-896. e9, 2012
2302012
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis
E Shoshan, AK Mobley, RR Braeuer, T Kamiya, L Huang, ME Vasquez, ...
Nature cell biology 17 (3), 311-321, 2015
2292015
Autocrine effects of tumor-derived complement
MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ...
Cell reports 6 (6), 1085-1095, 2014
2062014
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
RS Redis, AM Sieuwerts, MP Look, O Tudoran, C Ivan, R Spizzo, X Zhang, ...
Oncotarget 4 (10), 1748, 2013
2052013
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
M Haemmerle, ML Taylor, T Gutschner, S Pradeep, MS Cho, J Sheng, ...
Nature communications 8 (1), 310, 2017
2022017
Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-α in Breast Cancer
L Jin, O Wessely, EG Marcusson, C Ivan, GA Calin, SK Alahari
Cancer research 73 (9), 2884-2896, 2013
1932013
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
Y Zhou, G Wan, R Spizzo, C Ivan, R Mathur, X Hu, X Ye, J Lu, F Fan, L Xia, ...
Molecular oncology 8 (1), 83-92, 2014
1872014
Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer
Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ...
Journal of the National Cancer Institute 105 (19), 1485-1495, 2013
1822013
The system can't perform the operation now. Try again later.
Articles 1–20